Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-05-01
2011-11-15
Shameem, Golam M (Department: 1622)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S215000, C548S235000, C548S236000, C546S184000, C546S192000, C546S209000, C544S358000, C544S359000, C544S369000, C514S315000, C514S326000, C514S254020
Reexamination Certificate
active
08058299
ABSTRACT:
Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity, type II diabetes mellitus and metabolic syndrome.
REFERENCES:
patent: 3250771 (1966-05-01), Leonard et al.
patent: 3929793 (1975-12-01), Popelak et al.
patent: 4066654 (1978-01-01), Adelstein et al.
patent: 7015218 (2006-03-01), Ushio et al.
patent: 7094896 (2006-08-01), Ding et al.
patent: 7244727 (2007-07-01), Fox et al.
patent: 7317125 (2008-01-01), Bolin et al.
patent: 7714126 (2010-05-01), Bolin et al.
patent: 2004/0019067 (2004-01-01), Armistead et al.
patent: 2007/0123504 (2007-05-01), Bolin et al.
patent: 1 535 915 (2005-06-01), None
patent: WO 03/020269 (2003-03-01), None
patent: WO 2006/134317 (2006-12-01), None
patent: WO2007/060140 (2007-05-01), None
patent: 2008141976 (2008-11-01), None
The International Search Report and Written Opinion by the International Searching Authority, issued on Jul. 30, 2008, in the PCT application No. PCT/EP2008/055843.
Zhao et al., “Validation of Diacyl Glycerolacyltransferase I as a Novel Target for the Treatment of Obesity and Dyslipidemia Using a Potent and Selective Small Molecule Inhibitor,” J. Med. Chem., 2008, 51 (3), pp. 380-383.
The International Search Report and Written Opinion by the International Searching Authority, issued on Mar. 2, 2010, in the PCT application No. PCT/US09/68048.
The restriction requirement for Application No. 12/113,295, issued on Mar. 3, 2010.
The restriction requirement for Application No. 12/113,275, issued on Mar. 10, 2010.
Mishra et al., “A molecular model for diacylglycerol acyltransferase from Mortierella ramanniana var. angulispora,” Bioinformation. 2009; 3(9): 394-398.
Oh et al., “Diacylglycerol acyltransferase-inhibitory compounds from Erythrina senegalensis,” Archives of Pharmacal Research, 32(1), pp. 43-47, Jan. 2009.
Birch et al., “Discovery of a potent, selective, and orally efficacious pyrimidinooxazinyl bicyclooctaneacetic acid diacylglycerol acyltransferase-1 inhibitor,” J. Med Chem. Mar. 26, 2009;52(6)1558-68.
The International Search Report and Written Opinion by the International Searching Authority, issued on Apr. 2, 2010, in the PCT application No. PCT/US09/64971.
Bolin David Robert
Cheung Adrian Wai-Hing
Firooznia Fariborz
Hamilton Matthew Michael
McDermott Lee Apostle
Elrifi Ivor R.
Erlacher Heidi A.
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
Shameem Golam M
VIA Pharmaceuticals, Inc.
LandOfFree
Diacylglycerol acyltransferase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diacylglycerol acyltransferase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diacylglycerol acyltransferase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4281325